Central Venous Catheters - Medical Devices Pipeline Assessment, 2017

2017-05-05
Price :
Published : May-2017
No. of Pages : 71
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Central Venous Catheters Overview 6
3 Products under Development 7
3.1 Central Venous Catheters - Pipeline Products by Stage of Development 7
3.2 Central Venous Catheters - Pipeline Products by Segment 8
3.3 Central Venous Catheters - Pipeline Products by Territory 9
3.4 Central Venous Catheters - Pipeline Products by Regulatory Path 10
3.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date 11
3.6 Central Venous Catheters - Ongoing Clinical Trials 12
4 Central Venous Catheters - Pipeline Products under Development by Companies 13
4.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development 13
4.2 Central Venous Catheters - Pipeline Products by Stage of Development 14
5 Central Venous Catheters Companies and Product Overview 15
5.1 Ash Access Technology Inc Company Overview 15
5.1.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Bactiguard AB Company Overview 16
5.2.1 Bactiguard AB Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Bluegrass Vascular Technologies Inc Company Overview 17
5.3.1 Bluegrass Vascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Charite - Universitatsmedizin Berlin Company Overview 19
5.4.1 Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Globe Medical Tech Inc Company Overview 20
5.5.1 Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 i360medical Limited Company Overview 21
5.6.1 i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 Infusense Corp Company Overview 22
5.7.1 Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Marvao Medical Devices Limited Company Overview 23
5.8.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 23
5.9 Nipro Corp Company Overview 24
5.9.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 24
5.10 Pavmed Inc Company Overview 25
5.10.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.11 S3V Vascular Technologies Company Overview 26
5.11.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 26
5.12 Sharklet Technologies, Inc. Company Overview 27
5.12.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.13 Silver Bullet Therapeutics, Inc. Company Overview 28
5.13.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.14 Teleflex Inc Company Overview 29
5.14.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.15 The University of Utah Company Overview 30
5.15.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 30
5.16 University of Illinois at Chicago Company Overview 31
5.16.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
5.17 Vascular Access Technologies, Inc. Company Overview 32
5.17.1 Vascular Access Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.18 Vindica Therapeutics, Inc Company Overview 33
5.18.1 Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 33
6 Central Venous Catheters- Recent Developments 34
6.1 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 34
6.2 Apr 24, 2017: First Patients Enrolled In Bluegrass Vascular Post-Market SAVE Study 36
6.3 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 36
6.4 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 37
6.5 Apr 03, 2017: Retractable Technologies Reports Results for the Year 2016 37
6.6 Mar 31, 2017: B. Braun continues its sales and earnings growth 38
6.7 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 40
6.8 Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer 41
6.9 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 42
6.10 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 42
6.11 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 42
6.12 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 43
6.13 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 44
6.14 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 44
6.15 Feb 22, 2017: Change in the B. Braun Management Board 46
6.16 Dec 09, 2016: Centurion Recalls Multi-Med Single Lumen Catheters due to Excess Material that May Split or Separate 46
6.17 Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit's Opinion 47
6.18 Nov 14, 2016: Retractable Technologies Reports Results as of September 30, 2016 47
6.19 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 49
6.20 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 50
6.21 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 51
6.22 Oct 10, 2016: Teleflex Receives FDA Clearance for ARROW JACC with Chlorag+ard Technology and Tunneler 54
6.23 Sep 13, 2016: B. Braun To Showcase Introcan Safety IV Catheter at AVA 54
6.24 Sep 13, 2016: B. Braun To Showcase Introcan Safety 3 Closed IV Catheter at AVA 55
6.25 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 55
6.26 Aug 30, 2016: Bluegrass Vascular Secures CE Mark Approval and Announces Successful Commercial Use of The Surfacer Inside-Out Access Catheter System 55
6.27 Aug 16, 2016: PAVmed Announces Second Quarter 2016 Financial Results and Provides Business Update 56
6.28 Aug 16, 2016: Retractable Technologies Reports Results as of June 30, 2016 57
6.29 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 59
6.30 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 59
6.31 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 61
6.32 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 63
6.33 Jun 09, 2016: Patient and Healthcare Worker Safety Key Areas of Focus for B. Braun Medical at APIC 63
6.34 Jun 03, 2016: LEPUCARE established in India 64
6.35 May 17, 2016: Retractable Technologies Reports Results for the First Quarter of 2016 64
6.36 May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results 65
6.37 May 13, 2016: B. Braun Focused on Helping Educate Nurses About USP and Improving Vascular Access at INS 2016 66
6.38 May 10, 2016: ICU Medical Announces First Quarter 2016 Results 67
7 Appendix 68
7.1 Methodology 68
7.2 About GlobalData 71
7.3 Contact Us 71
7.4 Disclaimer 71

1.1 List of Tables
Table 1: Central Venous Catheters - Pipeline Products by Stage of Development 7
Table 2: Central Venous Catheters - Pipeline Products by Segment 8
Table 3: Central Venous Catheters - Pipeline Products by Territory 9
Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path 10
Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 11
Table 6: Central Venous Catheters - Ongoing Clinical Trials 12
Table 7: Central Venous Catheters Companies - Pipeline Products by Stage of Development 13
Table 8: Central Venous Catheters - Pipeline Products by Stage of Development 14
Table 9: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 15
Table 10: BaxCath Impregnation System - Product Status 15
Table 11: BaxCath Impregnation System - Product Description 15
Table 12: Bactiguard AB Pipeline Products & Ongoing Clinical Trials Overview 16
Table 13: Transvascular Injection Catheter - Product Status 16
Table 14: Transvascular Injection Catheter - Product Description 16
Table 15: Bluegrass Vascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 16: Surfacer Inside-Out Access Catheter System - Product Status 17
Table 17: Surfacer Inside-Out Access Catheter System - Product Description 17
Table 18: Bluegrass Vascular Technologies Inc - Ongoing Clinical Trials Overview 18
Table 19: Surfacer Inside-Out Access Catheter System - Clinical Study of the Surfacer Inside-Out Access Catheter System 18
Table 20: Surfacer Inside-Out Access Catheter System - Surfacer System to Facilitate Access in Venous Occlusions 18
Table 21: Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview 19
Table 22: Central Venous Permanent Catheter - Product Status 19
Table 23: Central Venous Permanent Catheter - Product Description 19
Table 24: Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 25: Safety IV Catheter - Product Status 20
Table 26: Safety IV Catheter - Product Description 20
Table 27: i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview 21
Table 28: Suture-Less Insertion And Stabilization Device - IV Catheter Lines - Product Status 21
Table 29: Suture-Less Insertion And Stabilization Device - IV Catheter Lines - Product Description 21
Table 30: Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 22
Table 31: Infusense System - Product Status 22
Table 32: Infusense System - Product Description 22
Table 33: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 23
Table 34: NexSite 8Fr Single Lumen Central Venous Catheter - Product Status 23
Table 35: NexSite 8Fr Single Lumen Central Venous Catheter - Product Description 23
Table 36: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 24
Table 37: Biocompatible Intravenous Catheter - Product Status 24
Table 38: Biocompatible Intravenous Catheter - Product Description 24
Table 39: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 40: NextCath - Product Status 25
Table 41: NextCath - Product Description 25
Table 42: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 26
Table 43: 3V AGILE - Product Status 26
Table 44: 3V AGILE - Product Description 26
Table 45: Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 46: Sharklet Central Venous Catheter - Product Status 27
Table 47: Sharklet Central Venous Catheter - Product Description 27
Table 48: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 49: Cathanic Venous Catheter - Product Status 28
Table 50: Cathanic Venous Catheter - Product Description 28
Table 51: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 52: ARROW JACC Nurse Insertion CVC System - Product Status 29
Table 53: ARROW JACC Nurse Insertion CVC System - Product Description 29
Table 54: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 30
Table 55: WIN NIC Central Venous Catheter Introducer Kit - Product Status 30
Table 56: WIN NIC Central Venous Catheter Introducer Kit - Product Description 30
Table 57: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
Table 58: Extendable Intravenous Catheter - Product Status 31
Table 59: Extendable Intravenous Catheter - Product Description 31
Table 60: Vascular Access Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 61: SAFECVAD - Product Status 32
Table 62: SAFECVAD - Product Description 32
Table 63: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 64: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Status 33
Table 65: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Description 33
Table 66: Glossary 70

1.2 List of Figures
Figure 1: Central Venous Catheters - Pipeline Products by Stage of Development 7
Figure 2: Central Venous Catheters - Pipeline Products by Segment 8
Figure 3: Central Venous Catheters - Pipeline Products by Territory 9
Figure 4: Central Venous Catheters - Pipeline Products by Regulatory Path 10
Figure 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 11
Figure 6: Central Venous Catheters - Ongoing Clinical Trials 12
Filed in: Medical Device
Publisher : GlobalData